SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists

Giant prolactinomas are tumors with a large size > 4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists, mainly cabergoline (CAB), are the first-line choice in the treatment of these tumors. Objective: To assess the efficacy, safety and long-t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Mallea Gil, Susana, Diez, Sabrina, Stalldecker, Graciela, Palazzo, Adriana, Sosa, Maria de los Angeles, Telares, Noelia, Peressotti, Bruno, Ballarino, Carolina
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2019
Témata:
Neuroendocrinology and Pituitary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553132/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-448
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky